Side Effects of Methylphenidate and Desipramine Alone and in Combination in Children

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 32, Issue 5, 1993, Pages 1065-1072

  PATAKI, CAROLY S ^a   CARLSON, GABRIELLE A ^a   KELLY, KEVIN L ^a   RAPPORT, MARK D ^a   BIANCANIELLO, THOMAS M ^a  

^a NONE

Author keywords

attention deficit hyperactivity disorder; cardiovascular effects; comor bidity; depression; desipramine; methylphenidate; side effects

Indexed keywords

DESIPRAMINE; METHYLPHENIDATE;

ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ELECTROCARDIOGRAPHY MONITORING; FATIGUE; HEADACHE; HEART RATE; HUMAN; MALE; MINIMAL BRAIN DYSFUNCTION; NAUSEA; ORAL DRUG ADMINISTRATION; SCHOOL CHILD; SINUS TACHYCARDIA; TREMOR; VOMITING; XEROSTOMIA;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMORBIDITY; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DESIPRAMINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; METHYLPHENIDATE;

EID: 0027317595     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199309000-00028     Document Type: Article

References (56)

1. Sudden death in children treated with a tricyclic antidepressant
2. The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action
3. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation
4. Clinical comment: sudden death in children treated with a tricyclic antidepressant
5. A double-blind placebo controlled study of desipramine in the treatment of ADD: I: Efficacy
6. A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings
7. Attention deficit disorder and the effect of methylphenidate on attention, behavioral and cardiovascular functioning
8. Imipramine in preschool autistic and schizophrenic children
9. Inpatient Global Rating Scale (IGRS)
10. Psychotropic drug side effects in children
11. Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels and clinical response
12. Hypertensive episodes after adding methylphenidate (Ritalin) to tricyclic antidepressants: report of three cases and review of clinical advantages
13. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings
14. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
15. Clinical comment: commentary on unexplained deaths of children on Norpramin®
16. Nortriptyline in major depressive disorder in children
17. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year olds with major depressive disorder
18. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: A review
19. Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate
20. Clinical effects of imipramine an methylphenidate in hyperactive children
21. A review of the psychophysiological research with hyperkinetic children
22. Depression and symptoms of attention deficit disorder with hyperactivity
23. Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study
24. Attention deficit disorder and methylphenidate: a multi-step analysis of dose-response effects on children's cardiovascular functioning. International Clinical
25. Depressive states and drugs-III. Use of methylphenidate (Ritalin) in open psychiatric settings and in office practice
26. Psychiatric comorbidity in patients with attention deficit disorder: a controlled study
27. Retrospective assessment of child psychopathology with the Kiddie-SADS-E
28. Inhibition of imipramine metabolism by methylphenidate
29. Imipramine and seizures
30. Imipramine treatment of depressed children: a double-blind pilot study
31. Tricyclic antidepressants in the treatment of children with ADD
32. Sudden death and tricyclic antidepressants: clinical considerations for children
33. Preliminary studies of the reliability and validity of the children's depression rating scale
34. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report
35. Imipramine in prepubertal major depressive disorders
36. Imipramine and methylphenidate treatments of hyperactive boys
37. New drug trials in attention deficit disorder
38. Attention deficit disorder with hyperactivity: differential effects of methylphenidate on impulsivity
39. Hyperactivity and methylphenidate: rate-dependent effects on attention
40. Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings
41. Psychostimulant effects on learning and cognitive function: findings and implications for children with attention deficit hyperactivity disorder
42. Methylphenidate and desipramine in hospitalized children I. Separate and combined effects on cognitive function
43. Sudden death in children receiving Norpramin-R: a review of three reported cases and commentary
44. Side effects from long term use of stimulants in children
45. Imipramine side effects in children
46. Drug combinations in the treatment of refractory depression: a review
47. Clinical comment: cardiotoxicity of the tricyclics
48. Methylphenidate in children—effect of dosage
49. Imipramine and methylphenidate in hyperactive children
50. A potential use for methylphenidate with tricyclic antidepressants
51. Amitriptyline and methylphenidate treatment of behaviorally disordered children
52. Clinical and metabolic studies with imipramine in man